MERAM LAB has a total of 90 patent applications. Its first patent ever was published in 1969. It filed its patents most often in Australia, Canada and EPO (European Patent Office). Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and foods and drinks are ARYAN RAM CHANDER, LIADE SA LAB and HOECHST ROUSSEL PHARMA.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 8 | |
#2 | Canada | 8 | |
#3 | EPO (European Patent Office) | 8 | |
#4 | France | 8 | |
#5 | South Africa | 6 | |
#6 | African Intellectual Property Organization | 5 | |
#7 | United States | 5 | |
#8 | WIPO (World Intellectual Property Organization) | 5 | |
#9 | Denmark | 4 | |
#10 | Finland | 4 | |
#11 | Norway | 4 | |
#12 | Tunisia | 4 | |
#13 | Morocco | 3 | |
#14 | Germany | 2 | |
#15 | Spain | 2 | |
#16 | Ireland | 2 | |
#17 | Austria | 1 | |
#18 | Belgium | 1 | |
#19 | Switzerland | 1 | |
#20 | United Kingdom | 1 | |
#21 | Greece | 1 | |
#22 | Italy | 1 | |
#23 | Japan | 1 | |
#24 | Mexico | 1 | |
#25 | New Zealand | 1 | |
#26 | Portugal | 1 | |
#27 | Sweden | 1 | |
#28 | USSR (Union of Socialist Soviet Republics) | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Acyclic or carbocyclic compounds | |
#4 | Medical preparations | |
#5 | Special acyclic compounds | |
#6 | Dairy products |
# | Name | Total Patents |
---|---|---|
#1 | Ollivier Roland | 33 |
#2 | Buzas Andre | 27 |
#3 | Merour Jean-Yves | 14 |
#4 | Andre Buzas | 13 |
#5 | Roland Ollivier | 11 |
#6 | Laurent Elisabeth | 11 |
#7 | Jean-Yves Merour | 9 |
#8 | Miocque Marcel | 7 |
#9 | Durlach Jean Pierre | 7 |
#10 | Binet Pierre | 7 |
Publication | Filing date | Title |
---|---|---|
FR2717803A1 | Substituted derivatives of nitrogen heterocycles and their isomers, active on the central nervous system, process for obtaining them and pharmaceutical compositions containing them. | |
FR2708611A1 | Codeine salt of 2- (3-benzoylphenyl) propionic acid, process for obtaining it and pharmaceutical compositions containing it. | |
WO9302087A1 | Gallium (iii) complexes, process for their obtention and pharmaceutical compositions containing them | |
FR2693722A1 | N-cycloalkylpiperazine derivatives, process for obtaining them and pharmaceutical compositions containing them. | |
FR2687401A1 | 1,4-DIALKYLPIPERAZINE DERIVATIVES, OBTAINING METHODS AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | |
IE881462L | Hydrazine derivatives. | |
OA08734A | Hydrazine derivatives, process for obtaining them and pharmaceutical compositions containing them. | |
IE872261L | Benzhydryloxyethylpiperidines | |
CA1218895A | Milk and milk products depleted or not depleted in calcium and enriched in magnesium | |
PT76970A | Process for obtaining novel amino- (and imino) salts-n-substituted alpha, omega-sulphonic acids | |
EP0059148A1 | Gallium chloride, an anti-cancer drug | |
US4355043A | Novel derivatives of 3-aminopropanesulfonic acid having a reinforced activity on membrane | |
DE1936749A1 | Pharmaceutical composition suitable for the treatment of diseases of the mind |